Effects of L-Arginine on Bone Metabolism: Evidence from In Vitro and In Vivo Models
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178484 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Clara Pertusa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain. Hauptthemen laut MEDLINE: Arginine, Osteogenesis, Bone and Bones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, ISCIII, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Despite the rising incidence of osteoporosis (the most common bone disorder) as life expectancy increases worldwide, the genetic and metabolic factors contributing to this multifactorial disease are still poorly understood. This study investigated the role of arginine metabolism in bone formation and its potential for preventing bone loss in postmenopausal osteoporosis. The osteogenic effects of arginine were evaluated in vitro by determining calcium mineral deposition and the expression of marker genes in the human osteoblastic cell line Saos-2. In vivo analyses were conducted in ovariectomized mice treated with arginine, focusing on femoral bone microarchitecture, marker gene expression and serum metabolite profiles. Arginine treatment enhanced calcium deposition and osteoblastic differentiation in vitro. In contrast, however, this treatment had a deleterious effect in vivo, exacerbating trabecular bone loss. These results are particularly relevant given the wide availability of arginine as a dietary supplement, and our findings underscore the necessity of verifying the safety of nutritional supplements in different populations and in the presence of disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Unit, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
- Department of Internal Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands.
- Department of Paediatrics, Obstetrics and Gynaecology, University of Valencia, 46010 Valencia, Spain.
- Department of Biochemistry and Molecular Biology, University of Valencia, 46010 Valencia, Spain.
- Salus Vitae Women's Health Clinical Centre, 46004 Valencia, Spain.
- Department of Cellular Biology, Functional Biology and Physical Anthropology, University of Valencia, 46100 Burjassot, Spain.
ORCID-Profile: Clara Pertusa, Álvaro Carrasco-García, Rosa Aliaga, Antonio Cano, Juan J Tarín, Miguel Ángel García-Pérez
Förderung
- Ministerio de Ciencia e Innovación
- ISCIII
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación
- EU FEDER Program
Zitieren
APA
Pertusa, C., Carrasco-García, Á., Aliaga, R., Suay, L., Alonso-Iglesias, E., Cano, A., Tarín, J. J., & García-Pérez, M. Á. (2025). Effects of L-Arginine on Bone Metabolism: Evidence from In Vitro and In Vivo Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178484
Vancouver
Pertusa C, Carrasco-García Á, Aliaga R, Suay L, Alonso-Iglesias E, Cano A, et al. Effects of L-Arginine on Bone Metabolism: Evidence from In Vitro and In Vivo Models. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178484
BibTeX
@article{Pertusa2025,
author = {Pertusa, Clara and Carrasco-García, Álvaro and Aliaga, Rosa and Suay, Loreto and Alonso-Iglesias, Eulalia and Cano, Antonio and Tarín, Juan J and García-Pérez, Miguel Ángel},
title = {Effects of L-Arginine on Bone Metabolism: Evidence from In Vitro and In Vivo Models},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178484}
}
EUVIMED